Safety and Efficacy of Oral Human Parathyroid Hormone (1‐34) in Hypoparathyroidism: An Open‐Label Study

ABSTRACT The standard treatment of primary hypoparathyroidism (hypoPT) with oral calcium supplementation and calcitriol (or an analog), intended to control hypocalcemia and hyperphosphatemia and avoid hypercalciuria, remains challenging for both patients and clinicians. In 2015, human parathyroid ho...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of bone and mineral research 2021-06, Vol.36 (6), p.1060-1068
Hauptverfasser:	Ish‐Shalom, Sofia, Caraco, Yoseph, Khazen, Nariman Saba, Gershinsky, Michal, Szalat, Auryan, Schwartz, Phillip, Arbit, Ehud, Galitzer, Hillel, Tang, Jonathan CY, Burshtein, Gregory, Rothner, Ariel, Raskin, Arthur, Blum, Miriam, Fraser, William D
Format:	Artikel
Sprache:	eng
Schlagworte:	25-Hydroxyvitamin D Acetic acid Adult Adverse events Calcitriol Calcium Calcium (blood) Calcium (urinary) Calcium phosphates CALCIUM/PHOSPHATE DISORDERS Dietary supplements Dosage Excretion Humans Hypercalciuria Hyperphosphatemia Hypocalcemia HYPOPARATHYROIDISM Hypoparathyroidism - drug therapy Normocalcemia ORAL PARATHYROID HORMONE Original Parathyroid PARATHYROID HORMONE Parathyroid Hormone - adverse effects PARATHYROID‐RELATED DISORDERS Quality of Life Statistical analysis Teriparatide - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!